journal
https://read.qxmd.com/read/38284341/the-psychedelic-future-of-post-traumatic-stress-disorder-treatment
#21
REVIEW
Tamar Glatman Zaretsky, Kathleen M Jagodnik, Robert Barsic, Josimar Hernandez Antonio, Philip A Bonanno, Carolyn MacLeod, Charlotte Pierce, Hunter Carney, Morgan T Morrison, Charles Saylor, George Danias, Lauren Lepow, Rachel Yehuda
Post-traumatic stress disorder (PTSD) is a mental health condition that can occur following exposure to a traumatic experience. An estimated 12 million U.S. adults are presently affected by this disorder. Current treatments include psychological therapies (e.g., exposure-based interventions) and pharmacological treatments (e.g., selective serotonin reuptake inhibitors (SSRIs)). However, a significant proportion of patients receiving standard-of-care therapies for PTSD remain symptomatic, and new approaches for this and other trauma-related mental health conditions are greatly needed...
2024: Current Neuropharmacology
https://read.qxmd.com/read/38284340/thematic-selection-stress-and-stress-related-disorders-posttraumatic-stress-disorder-part-2
#22
EDITORIAL
Agorastos Agorastos
No abstract text is available yet for this article.
2024: Current Neuropharmacology
https://read.qxmd.com/read/38284336/thematic-selection-stress-and-stress-related-disorders-neurobiology-translational-aspects-of-stress-related-disorders-part-3
#23
EDITORIAL
Agorastos Agorastos
No abstract text is available yet for this article.
2024: Current Neuropharmacology
https://read.qxmd.com/read/38214276/thematic-selection-stress-and-stress-related-disorders-developmental-and-neuroendocrine-aspects-of-stress-and-stress-related-disorders-part-1
#24
EDITORIAL
Agorastos Agorastos
No abstract text is available yet for this article.
2024: Current Neuropharmacology
https://read.qxmd.com/read/37990610/preface
#25
JOURNAL ARTICLE
Ferdinando Nicoletti
No abstract text is available yet for this article.
2024: Current Neuropharmacology
https://read.qxmd.com/read/37644747/use-of-post-mortem-brain-tissue-in-investigations-of-obsessive-compulsive-disorder-a-systematic-review
#26
JOURNAL ARTICLE
Christine Lochner, Petrus J W Naudé, Dan J Stein
BACKGROUND: Post-mortem examination of the brain is a key strategy to increase our understanding of the neurobiology of mental disorders. While extensive post-mortem research has been undertaken on some mental disorders, others appear to have been relatively neglected. OBJECTIVE: The objective of the study was to conduct a systematic review of post-mortem research on obsessive-compulsive disorder (OCD). METHODS: A systematic review was performed in accordance with PRISMA guidelines to provide an overview of quantitative, qualitative, or mixed methods primary research studies on OCD...
2024: Current Neuropharmacology
https://read.qxmd.com/read/37550908/inflammation-in-posttraumatic-stress-disorder-dysregulation-or-recalibration
#27
JOURNAL ARTICLE
Kostas Patas, Dewleen G Baker, George P Chrousos, Agorastos Agorastos
Despite ample experimental data indicating a role of inflammatory mediators in the behavioral and neurobiological manifestations elicited by exposure to physical and psychologic stressors, causative associations between systemic low-grade inflammation and central nervous system inflammatory processes in posttraumatic stress disorder (PTSD) patients remain largely conceptual. As in other stress-related disorders, pro-inflammatory activity may play an equivocal role in PTSD pathophysiology, one that renders indiscriminate employment of anti-inflammatory agents of questionable relevance...
2024: Current Neuropharmacology
https://read.qxmd.com/read/37132142/treatment-of-posttraumatic-stress-disorder-a-state-of-the-art-review
#28
REVIEW
Lisa Burback, Suzette Brémault-Phillips, Mirjam J Nijdam, Alexander McFarlane, Eric Vermetten
This narrative state-of-the-art review paper describes the progress in the understanding and treatment of Posttraumatic Stress Disorder (PTSD). Over the last four decades, the scientific landscape has matured, with many interdisciplinary contributions to understanding its diagnosis, etiology, and epidemiology. Advances in genetics, neurobiology, stress pathophysiology, and brain imaging have made it apparent that chronic PTSD is a systemic disorder with high allostatic load. The current state of PTSD treatment includes a wide variety of pharmacological and psychotherapeutic approaches, of which many are evidence-based...
2024: Current Neuropharmacology
https://read.qxmd.com/read/38073106/biphasic-hormetic-like-effect-of-lebecetin-a-c-type-lectin-of-snake-venom-on-formalin-induced-inflammation-in-mice
#29
JOURNAL ARTICLE
Carmela Belardo, Jed Jebali, Serena Boccella, Rosmara Infantino, Antimo Fusco, Michela Perrone, Roozbe Bonsale, Iolanda Manzo, Monica Iannotta, Damiana Scuteri, Franca Ferraraccio, Iacopo Panares, Giovanna Ferrara, Francesca Guida, Livio Luongo, Enza Palazzo, Najet Srairi-Abid, Naziha Marrakchi, Sabatino Maione
BACKGROUND: Integrins, important extracellular matrix (ECM) receptor proteins, are affected by inflammation and can participate in the maintenance of many painful conditions. Although they are ubiquitous and changeable across all cell types, the roles of these cell adhesion molecules in pathological pain have not been fully explored. OBJECTIVE: We evaluated the effects of the subcutaneous injection of lebecetin, a C-type lectin isolated from Macrovipera lebetina snake venom, previously reported to inhibit α5β1 and αv integrin activity, on different components of inflammation induced by the formalin administration in the hind paw of mice...
December 8, 2023: Current Neuropharmacology
https://read.qxmd.com/read/38073105/redox-modulation-of-meniere-disease-by-coriolus-versicolor-treatment-a-nutritional-mushroom-approach-with-neuroprotective-potential
#30
JOURNAL ARTICLE
Rosanna Di Paola, Rosalba Siracusa, Roberta Fusco, Marialaura Ontario, Gaetano Cammilleri, Licia Pantano, Maria Scuto, Mario Tomasello, Sestina Spanò, Angela Trovato Salinaro, Ali S Abdelhameed, Vincenzo Ferrantelli, Antonio Arcidiacono, Tilman Fritsch, Gabriella Lupo, Anna Signorile, Luigi Maiolino, Salvatore Cuzzocrea, Vittorio Calabrese
BACKGROUND: Meniere's disease (MD) is a cochlear neurodegenerative disease. Hearing loss appears to be triggered by oxidative stress in the ganglion neurons of the inner ear. OBJECTIVE: Here, we confirm the variation of markers of oxidative stress and inflammation in patients with Meniere and hypothesize that chronic treatment with Coriolus mushroom helps in the response to oxidative stress and acts on α-synuclein and on NF-kB-mediated inflammatory processes...
December 8, 2023: Current Neuropharmacology
https://read.qxmd.com/read/38073104/in-vitro-blood-brain-barrier-models-for-neuroinfectious-diseases-a-narrative-review
#31
JOURNAL ARTICLE
Ahmad Hussein Badawi, Nur Afiqah Mohamad, Johnson Stanslas, Brian P Kirby, Vasantha Kumari Neela, Rajesh Ramasamy, Hamidon Basri
The blood-brain barrier (BBB) is a complex, dynamic, and adaptable barrier between the peripheral blood system and the central nervous system. While this barrier protects the brain and spinal cord from inflammation and infection, it prevents most drugs from reaching the brain tissue. With the expanding interest in the pathophysiology of BBB, the development of in vitro BBB models has dramatically evolved. However, due to the lack of a standard model, a range of experimental protocols, BBB-phenotype markers, and permeability flux markers was utilized to construct in vitro BBB models...
December 8, 2023: Current Neuropharmacology
https://read.qxmd.com/read/38031778/immunomodulatory-effects-of-clozapine-more-than-just-a-side-effect-in-schizophrenia
#32
JOURNAL ARTICLE
Andrea Amerio, Luca Magnani, Gabriele Arduino, Fabio Fesce, Renato de Filippis, Alberto Parise, Alessandra Costanza, Khoa D Nguyen, Daniele Saverino, Domenico De Berardis, Andrea Aguglia, Andrea Escelsior, Gianluca Serafini, Pasquale De Fazio, Mario Amore
Recent evidence suggests a possible relationship between the immune system and schizophrenia spectrum disorders (SSDs), as neuroinflammation appears to play a role in major psychiatric conditions. Neuroinflammation is as a broad concept representing a physiological protective response to infection or injury, but in some cases, especially if chronic, it may represent an expression of maladaptive processes, potentially driving to clinical dysfunction and neurodegeneration. Several studies are concurrently highlighting the importance of microglia, the resident immune cells of the central nervous system, in a huge number of neurodegenerative diseases, including multiple sclerosis, Alzheimer's and Parkinson's diseases, as well as SSDs...
November 28, 2023: Current Neuropharmacology
https://read.qxmd.com/read/38420787/the-integration-of-top-down-and-bottom-up-inputs-to-the-striatal-cholinergic-interneurons
#33
JOURNAL ARTICLE
Yan-Feng Zhang, John N J Reynolds
BACKGROUND: Cholinergic interneurons (ChIs) are important for learning and memory. They exhibit a multiphasic excitation-pause-rebound response to reward or sensory cues indicating a reward, believed to gate dopamine-dependent learning. Although ChIs receive extensive top-down inputs from the cortex and bottom-up inputs from the thalamus and midbrain, it is unclear which inputs are involved in the development of ChI multiphasic activity. METHODS: We used a single-unit recording of putative ChIs (pChIs) in response to cortical and visual stimulation to investigate how top-down and bottom-up inputs regulate the firing pattern of ChIs...
November 15, 2023: Current Neuropharmacology
https://read.qxmd.com/read/38037913/insights-into-the-role-of-copper-in-neurodegenerative-diseases-and-the-therapeutic-potential-of-natural-compounds
#34
JOURNAL ARTICLE
Guangcheng Zhong, Xinyue Wang, Jiaqi Li, Zhouyuan Xie, Qiqing Wu, Jiaxin Chen, Yiyun Wang, Ziying Chen, Xinyue Cao, Tianyao Li, Jinman Liu, Qi Wang
Neurodegenerative diseases encompass a collection of neurological disorders originating from the progressive degeneration of neurons, resulting in the dysfunction of neurons. Unfortunately, effective therapeutic interventions for these diseases are presently lacking. Copper (Cu), a crucial trace element within the human body, assumes a pivotal role in various biological metabolic processes, including energy metabolism, antioxidant defense, and neurotransmission. These processes are vital for the sustenance, growth, and development of organisms...
November 15, 2023: Current Neuropharmacology
https://read.qxmd.com/read/37921169/targeting-the-main-sources-of-reactive-oxygen-species-production-possible-therapeutic-implications-in-chronic-pain
#35
JOURNAL ARTICLE
Peng-Fei Cheng, Yuan-He, Meng-Meng Ge, Da-Wei Ye, Jian-Ping Chen, Jin-Xi Wang
Humans have long been combating chronic pain. In clinical practice, opioids are first- choice analgesics, but long-term use of these drugs can lead to serious adverse reactions. Finding new, safe and effective pain relievers that are useful treatments for chronic pain is an urgent medical need. Based on accumulating evidence from numerous studies, excess reactive oxygen species (ROS) contribute to the development and maintenance of chronic pain. Some antioxidants are potentially beneficial analgesics in the clinic, but ROS-dependent pathways are completely inhibited only by scavenging ROS directly targeting cellular or subcellular sites...
October 25, 2023: Current Neuropharmacology
https://read.qxmd.com/read/37881090/low-density-lipoprotein-cholesterol-reduction-therapies-for-secondary-prevention-in-patients-with-stroke-a-network-meta-analysis
#36
JOURNAL ARTICLE
Xing Wang, Jun Zheng, Yuqi Chen, Chao You, Lu Ma
BACKGROUND: Patients with previous strokes are at a higher risk of stroke recurrence. Current guidelines recommend a range of low-density lipoprotein cholesterol (LDL-C)-lowering treatments to reduce the risk of recurrent stroke. However, the optimal agent for decreasing LDL-C to lower the risk of recurrent stroke remains unclear. This study aimed to assess the relative effects of various LDL-C -lowering agents for secondary stroke prevention. METHODS: Several databases were searched from inception up to 2022...
October 20, 2023: Current Neuropharmacology
https://read.qxmd.com/read/37859307/smoking-symptoms-improvement-and-total-antioxidant-capacity-in-patients-with-drug-naive-first-episode-schizophrenia-a-prospective-cohort-study
#37
JOURNAL ARTICLE
Zhiyong Gao, Meihong Xiu, Jiahong Liu, Fengchun Wu, Xiangyang Zhang
BACKGROUND: It has been hypothesized that smoking is associated with the severity of negative symptoms. Until now, no studies have investigated whether the impact of smoking on negative symptoms is dependent on antioxidants. This study was designed to evaluate the effect of smoking on therapeutic response and total antioxidants capacity (TAOC) in antipsychotic-naïve first-episode (ANFE) patients. METHODS: The severity of the patient's symptoms was assessed using the Positive and Negative Syndrome Scale (PANSS)...
October 19, 2023: Current Neuropharmacology
https://read.qxmd.com/read/37898823/inflammation-autoimmunity-and-neurodegenerative-diseases-therapeutics-and-beyond
#38
JOURNAL ARTICLE
Jenny Valentina Garmendia, Claudia Valentina De Sanctis, Viswanath Das, Narendran Annadurai, Marián Hajduch, Juan Bautista De Sanctis
Neurodegenerative disease (ND) incidence has recently increased due to improved life expectancy. Alzheimer's (AD) or Parkinson's disease (PD) are the most prevalent NDs. Both diseases are poly genetic, multifactorial and heterogenous. Preventive medicine, a healthy diet, exercise, and controlling comorbidities may delay the onset. After the diseases are diagnosed, therapy is needed to slow progression. Recent studies show that local, peripheral and age-related inflammation accelerates NDs' onset and progression...
October 17, 2023: Current Neuropharmacology
https://read.qxmd.com/read/37873949/three-decades-of-valproate-a-current-model-for-studying-autism-spectrum-disorder
#39
JOURNAL ARTICLE
David Zarate-Lopez, Ana Laura Torres-Chávez, Alma Yadira Gálvez-Contreras, Oscar Gonzalez-Perez
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder with increased prevalence and incidence in recent decades. Its etiology remains largely unclear, but it seems to involve a strong genetic component and environmental factors that, in turn, induce epigenetic changes during embryonic and postnatal brain development. In recent decades, clinical studies have shown that inutero exposure to valproic acid (VPA), a commonly prescribed antiepileptic drug, is an environmental factor associated with an increased risk of ASD...
October 16, 2023: Current Neuropharmacology
https://read.qxmd.com/read/37855285/sex-differences-in-stress-response-classical-mechanisms-and-beyond
#40
JOURNAL ARTICLE
Georgia E Hodes, Debra Bangasser, Ioannis Sotiropoulos, Nikolaos Kokras, Christina Dalla
Neuropsychiatric disorders, which are associated with stress hormone dysregulation, occur at different rates in men and women. Moreover, nowadays, preclinical and clinical evidence demonstrates that sex and gender can lead to differences in stress responses that predispose males and females to different expressions of similar pathologies. In this curated review, we focus on what is known about sex differences in classic mechanisms of stress response, such as glucocorticoid hormones and corticotrophin-releasing factor (CRF), which are components of the hypothalamicpituitary- adrenal (HPA) axis...
October 5, 2023: Current Neuropharmacology
journal
journal
40311
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.